Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.43T
1-Year Return 25.4%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Quarter Return
+9.83%
1 Year Return
+25.4%
3 Year Return
+109.59%
5 Year Return
+197.61%
10 Year Return
+489.39%
AUM
$851B
AUM Growth
+$80.9B
Cap. Flow
+$21.3B
Cap. Flow %
2.51%
Top 10 Hldgs %
25.93%
Holding
4,889
New
87
Increased
3,364
Reduced
613
Closed
135

Sector Composition

1 Technology 28.26%
2 Healthcare 13.33%
3 Financials 12.08%
4 Consumer Discretionary 10.85%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
UBX
3826
DELISTED
Unity Biotechnology
UBX
$322K ﹤0.01%
126,108
+3,125
+3% +$7.97K
NPCE icon
3827
Neuropace
NPCE
$324M
$321K ﹤0.01%
71,515
AAMC
3828
DELISTED
Altisource Asset Mgmt Corp
AAMC
$319K ﹤0.01%
9,642
-1,619
-14% -$53.5K
GATE
3829
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$318K ﹤0.01%
30,676
+171
+0.6% +$1.78K
CKPT
3830
DELISTED
Checkpoint Therapeutics
CKPT
$318K ﹤0.01%
128,587
+56,997
+80% +$141K
VIRX
3831
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$316K ﹤0.01%
224,438
ORKA
3832
Oruka Therapeutics, Inc. Common Stock
ORKA
$604M
$316K ﹤0.01%
12,970
ZFOX
3833
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$315K ﹤0.01%
315,333
+49,633
+19% +$49.6K
MEIP icon
3834
MEI Pharma
MEIP
$98.2M
$315K ﹤0.01%
47,833
-3
-0% -$20
TIL icon
3835
Instil Bio
TIL
$171M
$314K ﹤0.01%
28,529
-32,223
-53% -$355K
AIRT icon
3836
Air T
AIRT
$67.8M
$313K ﹤0.01%
12,482
-2,519
-17% -$63.2K
PASG icon
3837
Passage Bio
PASG
$22M
$312K ﹤0.01%
16,596
CELL
3838
DELISTED
PhenomeX Inc. Common Stock
CELL
$312K ﹤0.01%
636,160
-597,410
-48% -$293K
BIOR
3839
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$311K ﹤0.01%
8,081
+3,672
+83% +$141K
SLAM
3840
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$310K ﹤0.01%
29,043
CYT
3841
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$309K ﹤0.01%
119,032
MBIO icon
3842
Mustang Bio
MBIO
$10.6M
$309K ﹤0.01%
995
+172
+21% +$53.4K
LPTH icon
3843
Lightpath Technologies
LPTH
$233M
$309K ﹤0.01%
228,684
MKUL
3844
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$308K ﹤0.01%
131,676
+44,920
+52% +$105K
USCT
3845
DELISTED
Roth CH Acquisition Co. Class A Ordinary Shares
USCT
$308K ﹤0.01%
29,046
NAMS icon
3846
NewAmsterdam Pharma
NAMS
$2.98B
$306K ﹤0.01%
25,768
+7,209
+39% +$85.7K
VRAR icon
3847
Glimpse Group
VRAR
$30.5M
$305K ﹤0.01%
85,806
ASRV icon
3848
AmeriServ Financial
ASRV
$48.2M
$305K ﹤0.01%
120,070
BWMX icon
3849
Betterware México
BWMX
$510M
$305K ﹤0.01%
23,570
GMGI icon
3850
Golden Matrix Group
GMGI
$139M
$303K ﹤0.01%
117,614